In8Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.24

+0.04 (+3.33%)

As of Sep 28, 10:37 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +3,172.6% upside

Low Target $25.27

Average Target $40.58

High Target $56.74

Current Price $1.24

Current
$1.24

Target
$40.58

$25.27 $40.58 avg $56.74

Scenario Analysis

Bear Case

$25.27

1,937.9%

Low target

Base Case

$40.58

+3,172.6%

Avg target

Bull Case

$56.74

+4,475.8%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$2.73

-54.6% from high

52-Week Low

$0.88

+40.9% from low

Target vs 52W High

$40.58

+1,386.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%